Profil
Regina Fritsche-Danielson is currently Director at SmartCella Holding AB and SVP, Head-Research & Early Development at AstraZeneca PLC since 2019.
Former positions include Director at Fluicell AB from 2022 to 2024 and Associate Professor at the University of Gothenburg.
Education includes a doctorate from the University of Gothenburg conferred in 1993.
Aktive Positionen von Regina Fritsche-Danielson
| Unternehmen | Position | Beginn |
|---|---|---|
| ASTRAZENECA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 |
SmartCella Holding AB
SmartCella Holding AB BiotechnologyHealth Technology Operates as a drug-delivery company that develops targeted therapeutic delivery platforms | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Regina Fritsche-Danielson
| Unternehmen | Position | Ende |
|---|---|---|
| FLUICELL AB | Direktor/Vorstandsmitglied | 28.08.2024 |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Regina Fritsche-Danielson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fluicell AB
Fluicell AB BiotechnologyHealth Technology Provides fluid platforms for multi-functional pipettes for cell-based pharmacology research | Health Technology |
SmartCella Holding AB
SmartCella Holding AB BiotechnologyHealth Technology Operates as a drug-delivery company that develops targeted therapeutic delivery platforms | Health Technology |
















